FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q1 2023

SEC EDGAR SourceSEC Filings

Top Holdings193 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

4.5M$1.8B9.9%
Increased

SALESFORCE.COM INC

3.5M$699.6M3.8%$165.48+17.38%
14 qtrssince 2019-Q4
Decreased
0

IQVIA HOLDINGS INC

3.2M$638.1M3.5%$146.64+32.94%
18 qtrssince 2018-Q4
Decreased
0

THERMO FISHER SCIENTIFIC INC

1M$604.6M3.3%$401.12+39.19%
14 qtrssince 2019-Q4
Decreased
0

HORIZON THERAPEUTICS PLC

5.4M$591.5M3.2%
8 qtrssince 2021-Q2
Increased
79

ALPHABET INC-CL C

5.5M$567.4M3.1%$98.46+2.14%
18 qtrssince 2018-Q4
Increased
88

TRANSUNION

8.6M$535.1M2.9%$86.82-30.19%
18 qtrssince 2018-Q4
Decreased
0

MICROSOFT CORP

1.7M$480.7M2.6%$160.26+73.53%
18 qtrssince 2018-Q4
Decreased
0
SJRSJRDelisted
Convertible

SHAW COMMUNICATIONS INC

15.8M$472.8M2.6%
8 qtrssince 2021-Q2
Increased
79

EXELIXIS INC

23.5M$455.5M2.5%$18.94-0.59%
18 qtrssince 2018-Q4
Increased
86

UNITEDHEALTH GROUP INC

866,000$409.3M2.2%$446.580.00%
1 qtr
New
81
AZNAZN
ADR

ASTRAZENECA PLC

5.9M$407.3M2.2%$114.74+15.49%
7 qtrssince 2021-Q3
Decreased
0

INTUIT INC

911,000$406.2M2.2%$381.37+13.15%
2 qtrssince 2022-Q4
Increased
54

ARAMARK

11.2M$402.3M2.2%$24.80+0.41%
10 qtrssince 2020-Q4
Increased
55

S&P GLOBAL INC

1.2M$397.1M2.2%$318.41+4.83%
4 qtrssince 2022-Q2
Increased
57

BOSTON SCIENTIFIC CORP

7.7M$385.5M2.1%$38.48+28.91%
11 qtrssince 2020-Q3
Decreased
0
YMMYMM
ADR

FULL TRUCK ALLIANCE CO LTD

43.8M$333.4M1.8%$7.94-6.12%
8 qtrssince 2021-Q2
Increased
49

DYNATRACE INC

7.8M$329.4M1.8%$41.22+15.50%
4 qtrssince 2022-Q2
Decreased
0

SERVICENOW INC

699,650$325.1M1.8%$102.15-13.92%
8 qtrssince 2021-Q2
Increased
51

ANTHEM INC

673,630$309.7M1.7%$300.45+46.44%
18 qtrssince 2018-Q4
Increased
52
$18.3B
AUM
193
Positions
Q1 2023
Filing
Rating · 1.5
Quarterly Portfolio Change
-7%Q4'21$20B+3%Q1'22$20.7B-11%Q2'22$18.4B-1%Q3'22$18.2B-7%Q4'22$16.9B+8%Q1'23$18.3B
Activity profile
$ moved · Q1'23
New15%Increased44%Decreased23%Exited18%
Composition
Equity vs derivatives
Equity90%Puts10%Calls0%
Holding period
Avg 1.8 years
<1Q7%1-4Q14%1-2Y47%2Y+32%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $18.3B across 193 positions as of Q1 2023. Top holdings: SPY (9.9%), CRM (3.8%), IQV (3.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q1 2023 Summary

Active quarter - 16 new positions, 66 exits, 36 increased. Top move: GOOG (INCREASED, conviction 88). Portfolio: $18.3B across 193 positions.

Top holdings by portfolio weight

Total AUM$16B
CRM3.82%
IQV3.48%
TMO3.30%
HZNP3.23%
GOOG3.10%
TRU2.92%
MSFT2.63%
SJR2.58%
EXEL2.49%
UNH2.24%
Other2.22%

Portfolio allocation by GICS sector

Sectors11
Healthcare33.34%
Technology18.76%
Unknown14.96%
Financial Services13.41%
Industrials8.34%
Communication Services5.34%
Real Estate2.13%
Basic Materials1.99%
Consumer Cyclical1.20%
Utilities0.54%
Other0.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used